Zydus Lifesciences Shares Rise After USFDA Approval for Cancer Drug
Zydus Lifesciences’ share price extended its gains for the third consecutive session on March 19, rising over 1% after the company received final approval from the US Food and Drug Administration (USFDA) for Apalutamide Tablets, 60 mg. At 9:20 AM, Zydus Lifesciences was trading at ₹916.05, up ₹12.95 or 1.43% on the BSE. The company […]
Zydus Lifesciences Shares Rise After USFDA Approval for Cancer Drug Read More »